Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zic2
|
ENSMUSG00000061524.8 | zinc finger protein of the cerebellum 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_122475420_122475579 | Zic2 | 64 | 0.778375 | 0.84 | 1.4e-15 | Click! |
chr14_122482761_122482958 | Zic2 | 4759 | 0.121119 | 0.82 | 1.4e-14 | Click! |
chr14_122482263_122482671 | Zic2 | 4367 | 0.124570 | 0.82 | 2.3e-14 | Click! |
chr14_122481225_122481538 | Zic2 | 3281 | 0.140500 | 0.80 | 1.4e-13 | Click! |
chr14_122478567_122478736 | Zic2 | 551 | 0.624952 | 0.80 | 1.7e-13 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_14306720_14307413 | 60.18 |
Gm26184 |
predicted gene, 26184 |
33755 |
0.17 |
chr13_71945270_71945421 | 32.35 |
Gm40999 |
predicted gene, 40999 |
11207 |
0.24 |
chr13_71946257_71946408 | 32.05 |
Gm40999 |
predicted gene, 40999 |
10220 |
0.24 |
chr13_71945541_71945692 | 27.60 |
Gm40999 |
predicted gene, 40999 |
10936 |
0.24 |
chr13_71945848_71945999 | 24.85 |
Gm40999 |
predicted gene, 40999 |
10629 |
0.24 |
chr18_12720218_12720585 | 24.47 |
Mir1948 |
microRNA 1948 |
5590 |
0.15 |
chr5_112239158_112239879 | 23.19 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr6_28980766_28981191 | 19.44 |
Gm3294 |
predicted gene 3294 |
656 |
0.73 |
chr17_56472537_56473329 | 18.55 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr1_38835547_38836894 | 17.62 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr5_32713265_32714499 | 17.02 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr11_68151116_68151310 | 16.14 |
C78197 |
expressed sequence C78197 |
44940 |
0.13 |
chr8_4677704_4678740 | 15.92 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chr12_56458764_56459233 | 14.98 |
Sfta3-ps |
surfactant associated 3, pseudogene |
34326 |
0.12 |
chr7_76185076_76185361 | 14.54 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44669 |
0.17 |
chr13_88821410_88822253 | 14.51 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
189 |
0.97 |
chr4_109225194_109225586 | 14.22 |
Calr4 |
calreticulin 4 |
9095 |
0.2 |
chr14_14349938_14350878 | 14.17 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr10_34206475_34207143 | 13.99 |
Dse |
dermatan sulfate epimerase |
268 |
0.86 |
chrX_170810683_170812217 | 13.95 |
Gm15068 |
predicted gene 15068 |
58510 |
0.14 |
chr1_42695585_42695788 | 13.70 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
82 |
0.89 |
chr13_71946464_71946615 | 13.66 |
Gm40999 |
predicted gene, 40999 |
10013 |
0.24 |
chr18_25656334_25656645 | 13.51 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
57281 |
0.13 |
chr19_61225302_61226760 | 13.37 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr14_31131923_31132463 | 13.35 |
Nt5dc2 |
5'-nucleotidase domain containing 2 |
842 |
0.44 |
chr6_77243554_77244106 | 13.19 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
908 |
0.69 |
chr18_25678986_25679896 | 13.10 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr11_39794467_39794650 | 13.03 |
Gm24192 |
predicted gene, 24192 |
36098 |
0.21 |
chr7_57590461_57591180 | 12.92 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
302 |
0.92 |
chr18_72949026_72949703 | 12.70 |
Gm31908 |
predicted gene, 31908 |
28274 |
0.23 |
chr2_125060020_125060307 | 12.52 |
Slc24a5 |
solute carrier family 24, member 5 |
7961 |
0.19 |
chr6_75602973_75603165 | 12.47 |
4933439N06Rik |
RIKEN cDNA 4933439N06 gene |
29611 |
0.25 |
chr10_18743968_18744153 | 12.16 |
Arfgef3 |
ARFGEF family member 3 |
111 |
0.73 |
chr18_15552342_15552493 | 11.93 |
Aqp4 |
aquaporin 4 |
141435 |
0.04 |
chr2_74063919_74064096 | 11.91 |
A630050E04Rik |
RIKEN cDNA A630050E04 gene |
38335 |
0.15 |
chr15_75566838_75567525 | 11.86 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
35 |
0.96 |
chr10_75994691_75995012 | 11.70 |
Gm16220 |
predicted gene 16220 |
859 |
0.4 |
chr9_112118371_112118778 | 11.65 |
Mir128-2 |
microRNA 128-2 |
137 |
0.97 |
chr3_32817066_32817811 | 11.56 |
Usp13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
108 |
0.97 |
chr13_83727309_83727854 | 11.47 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr10_69574413_69574635 | 11.40 |
Gm46231 |
predicted gene, 46231 |
8163 |
0.26 |
chr9_35402474_35402797 | 11.39 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
18493 |
0.14 |
chr1_189187702_189188139 | 11.30 |
2900042K21Rik |
RIKEN cDNA 2900042K21 gene |
23093 |
0.18 |
chr11_71758404_71758886 | 11.30 |
Wscd1 |
WSC domain containing 1 |
7269 |
0.18 |
chr14_120507620_120507841 | 11.28 |
Rap2a |
RAS related protein 2a |
29286 |
0.21 |
chr13_13783865_13785053 | 11.23 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr12_29279690_29280795 | 11.19 |
Gm6989 |
predicted gene 6989 |
37326 |
0.21 |
chr2_33812630_33813034 | 11.17 |
Nron |
non-protein coding RNA, repressor of NFAT |
6973 |
0.22 |
chr17_37079144_37079337 | 11.01 |
Olfr90 |
olfactory receptor 90 |
6996 |
0.09 |
chr2_66041591_66042392 | 10.90 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
52080 |
0.12 |
chr16_21828247_21828594 | 10.90 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
2478 |
0.18 |
chr15_58976304_58977052 | 10.85 |
Mtss1 |
MTSS I-BAR domain containing 1 |
4139 |
0.18 |
chr2_136670530_136670925 | 10.83 |
Gm36967 |
predicted gene, 36967 |
9234 |
0.23 |
chr10_95619676_95619912 | 10.74 |
Gm33336 |
predicted gene, 33336 |
12445 |
0.13 |
chr14_34880683_34880940 | 10.72 |
Mir346 |
microRNA 346 |
13798 |
0.22 |
chr1_125911939_125912615 | 10.60 |
Lypd1 |
Ly6/Plaur domain containing 1 |
63 |
0.98 |
chr4_72384628_72385513 | 10.52 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr5_131794610_131795069 | 10.48 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
85430 |
0.06 |
chr16_46009777_46011157 | 10.46 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr19_61228253_61228788 | 10.37 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
91 |
0.95 |
chr1_39947267_39947431 | 10.35 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
16806 |
0.22 |
chr16_38742372_38743125 | 10.30 |
B4galt4 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 |
427 |
0.78 |
chr3_137547625_137547825 | 10.24 |
Gm4861 |
predicted gene 4861 |
4897 |
0.24 |
chr5_129762229_129762526 | 10.18 |
Psph |
phosphoserine phosphatase |
8778 |
0.1 |
chr13_78182236_78182416 | 10.15 |
Gm38604 |
predicted gene, 38604 |
833 |
0.51 |
chr13_29273638_29274140 | 10.09 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr15_78181729_78182061 | 10.08 |
Gm49694 |
predicted gene, 49694 |
7434 |
0.14 |
chr4_109977849_109978740 | 10.05 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr4_141011762_141012413 | 10.04 |
Mfap2 |
microfibrillar-associated protein 2 |
1443 |
0.27 |
chr8_55940261_55940432 | 10.03 |
Glra3 |
glycine receptor, alpha 3 subunit |
114 |
0.97 |
chr6_111844284_111844601 | 10.01 |
Gm22093 |
predicted gene, 22093 |
241190 |
0.02 |
chr13_60680942_60681179 | 9.90 |
Dapk1 |
death associated protein kinase 1 |
15353 |
0.17 |
chr7_79519799_79520848 | 9.87 |
Gm37608 |
predicted gene, 37608 |
3441 |
0.11 |
chr1_25180290_25180517 | 9.86 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
24320 |
0.16 |
chr12_92247060_92247465 | 9.84 |
Gm6841 |
predicted gene 6841 |
27885 |
0.23 |
chr13_94545846_94546035 | 9.76 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
3637 |
0.25 |
chr9_122571793_122572853 | 9.75 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr2_49619461_49620115 | 9.70 |
Kif5c |
kinesin family member 5C |
490 |
0.86 |
chr1_35869466_35870086 | 9.65 |
1110002O04Rik |
RIKEN cDNA 1110002O04 gene |
10069 |
0.21 |
chr6_54553141_54553306 | 9.64 |
Scrn1 |
secernin 1 |
1223 |
0.45 |
chr1_85089758_85090158 | 9.62 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr13_78203360_78204177 | 9.61 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
981 |
0.45 |
chr4_27988130_27988413 | 9.61 |
Tpm3-rs2 |
tropomyosin 3, related sequence 2 |
8634 |
0.29 |
chr5_27049317_27050134 | 9.59 |
Dpp6 |
dipeptidylpeptidase 6 |
332 |
0.92 |
chr11_52098162_52099642 | 9.55 |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
221 |
0.52 |
chr3_8310829_8311058 | 9.55 |
Gm5841 |
predicted gene 5841 |
16588 |
0.25 |
chr18_75724508_75724659 | 9.50 |
Ctif |
CBP80/20-dependent translation initiation factor |
27029 |
0.18 |
chr12_27064915_27065316 | 9.50 |
Gm9866 |
predicted gene 9866 |
49880 |
0.18 |
chr9_33233908_33234073 | 9.48 |
Gm47775 |
predicted gene, 47775 |
62254 |
0.12 |
chr12_49484164_49484347 | 9.47 |
1810007C17Rik |
RIKEN cDNA 1810007C17 gene |
3393 |
0.24 |
chr18_59061902_59062053 | 9.46 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
271 |
0.95 |
chr1_118911182_118911412 | 9.45 |
Mir6346 |
microRNA 6346 |
42923 |
0.16 |
chr10_81364518_81366962 | 9.43 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr6_24470565_24470733 | 9.42 |
Iqub |
IQ motif and ubiquitin domain containing |
44418 |
0.13 |
chr13_52457883_52458068 | 9.41 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr2_170838151_170838547 | 9.35 |
Dok5 |
docking protein 5 |
106542 |
0.07 |
chr16_16561093_16561486 | 9.34 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr7_63444022_63445137 | 9.33 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr4_104439745_104439896 | 9.33 |
Dab1 |
disabled 1 |
72230 |
0.13 |
chr13_54884394_54884554 | 9.31 |
Gm29431 |
predicted gene 29431 |
2996 |
0.19 |
chr5_97289764_97289960 | 9.27 |
Gm5560 |
predicted pseudogene 5560 |
25034 |
0.17 |
chr7_43488997_43489204 | 9.27 |
Iglon5 |
IgLON family member 5 |
975 |
0.29 |
chr16_23898319_23898514 | 9.22 |
Sst |
somatostatin |
7458 |
0.19 |
chr17_13759899_13761731 | 9.20 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr5_8820581_8820774 | 9.16 |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
4613 |
0.17 |
chr5_65106807_65107827 | 9.15 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr2_11391722_11392142 | 9.15 |
8030442B05Rik |
RIKEN cDNA 8030442B05 gene |
6569 |
0.1 |
chr6_129533069_129533908 | 9.12 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
63 |
0.68 |
chr18_23037418_23037876 | 9.04 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr1_92698831_92699536 | 9.01 |
Gm29483 |
predicted gene 29483 |
18019 |
0.12 |
chr10_52940614_52940777 | 8.97 |
Gm25664 |
predicted gene, 25664 |
35057 |
0.19 |
chr8_4492910_4494136 | 8.96 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr4_126648482_126648847 | 8.95 |
Gm12933 |
predicted gene 12933 |
16590 |
0.13 |
chr6_104493049_104493242 | 8.93 |
Cntn6 |
contactin 6 |
91 |
0.99 |
chrX_161480448_161480798 | 8.90 |
Prkaca-ps1 |
protein kinase, cAMP dependent, catalytic, alpha pseudogene 1 |
5862 |
0.33 |
chr9_45550156_45550508 | 8.87 |
Gm22069 |
predicted gene, 22069 |
84480 |
0.07 |
chr11_32009942_32010420 | 8.87 |
Nsg2 |
neuron specific gene family member 2 |
9679 |
0.21 |
chr2_150688525_150689141 | 8.86 |
Vsx1 |
visual system homeobox 1 |
527 |
0.68 |
chr3_101213398_101213615 | 8.85 |
Gm12486 |
predicted gene 12486 |
6107 |
0.18 |
chr6_22875703_22876165 | 8.84 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
157 |
0.97 |
chr13_51918714_51919107 | 8.79 |
Gm26651 |
predicted gene, 26651 |
54304 |
0.13 |
chr13_90913782_90914001 | 8.79 |
Atp6ap1l |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
8536 |
0.2 |
chr7_98120340_98120723 | 8.78 |
Myo7a |
myosin VIIA |
1007 |
0.52 |
chr14_28509611_28510106 | 8.75 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
760 |
0.59 |
chr11_28735281_28735484 | 8.71 |
Mir216b |
microRNA 216b |
10809 |
0.13 |
chr9_41011522_41012361 | 8.68 |
Crtam |
cytotoxic and regulatory T cell molecule |
7313 |
0.19 |
chr6_91839077_91839294 | 8.67 |
Grip2 |
glutamate receptor interacting protein 2 |
11935 |
0.16 |
chr8_12400836_12401454 | 8.63 |
Gm25239 |
predicted gene, 25239 |
4742 |
0.15 |
chr11_103840940_103841203 | 8.63 |
Nsf |
N-ethylmaleimide sensitive fusion protein |
13640 |
0.18 |
chrX_134620474_134620677 | 8.59 |
Gm7855 |
predicted gene 7855 |
5169 |
0.12 |
chr19_3429597_3429748 | 8.59 |
Gal |
galanin and GMAP prepropeptide |
15128 |
0.13 |
chr5_120436053_120436529 | 8.57 |
Gm27199 |
predicted gene 27199 |
4524 |
0.14 |
chr7_12779870_12780809 | 8.56 |
Zscan18 |
zinc finger and SCAN domain containing 18 |
315 |
0.58 |
chr11_4946958_4947325 | 8.52 |
Nefh |
neurofilament, heavy polypeptide |
923 |
0.47 |
chr7_87586675_87586826 | 8.49 |
Grm5 |
glutamate receptor, metabotropic 5 |
2352 |
0.42 |
chr4_69256161_69256473 | 8.43 |
Gm11404 |
predicted gene 11404 |
38804 |
0.22 |
chr5_30738536_30738777 | 8.42 |
Gm42764 |
predicted gene 42764 |
20376 |
0.12 |
chr10_109010570_109010914 | 8.41 |
Syt1 |
synaptotagmin I |
220 |
0.96 |
chr5_95991506_95991944 | 8.41 |
Gm7993 |
predicted gene 7993 |
17485 |
0.2 |
chr7_141070009_141070863 | 8.37 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
161 |
0.88 |
chr19_38263874_38264486 | 8.35 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
356 |
0.85 |
chrX_136708461_136708682 | 8.33 |
Tceal1 |
transcription elongation factor A (SII)-like 1 |
589 |
0.63 |
chr10_60115666_60116069 | 8.33 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
9399 |
0.18 |
chr11_4572974_4574056 | 8.32 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr2_146262046_146262668 | 8.31 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
982 |
0.51 |
chr19_54114913_54115287 | 8.30 |
Gm50186 |
predicted gene, 50186 |
30541 |
0.18 |
chr7_79590405_79591230 | 8.29 |
Gm45169 |
predicted gene 45169 |
1796 |
0.2 |
chr2_178154659_178154858 | 8.29 |
Phactr3 |
phosphatase and actin regulator 3 |
12825 |
0.24 |
chr7_44310178_44311500 | 8.28 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr4_3082761_3083956 | 8.26 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr12_28055447_28056122 | 8.25 |
Gm25923 |
predicted gene, 25923 |
4744 |
0.29 |
chr2_30718241_30719386 | 8.24 |
Gm14488 |
predicted gene 14488 |
1244 |
0.36 |
chr13_73604216_73604826 | 8.23 |
Clptm1l |
CLPTM1-like |
515 |
0.77 |
chr6_124915577_124916697 | 8.22 |
Ptms |
parathymosin |
608 |
0.37 |
chr14_72158563_72158782 | 8.20 |
Gm23735 |
predicted gene, 23735 |
27584 |
0.21 |
chr3_35405107_35405293 | 8.19 |
Gm43078 |
predicted gene 43078 |
8633 |
0.26 |
chr2_125059582_125059841 | 8.18 |
Slc24a5 |
solute carrier family 24, member 5 |
8413 |
0.19 |
chr12_3234876_3235557 | 8.18 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
288 |
0.88 |
chr2_59749338_59749707 | 8.17 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
6720 |
0.29 |
chr11_80428777_80429451 | 8.17 |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
424 |
0.83 |
chr7_49699721_49700100 | 8.15 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59205 |
0.11 |
chr18_38067840_38068871 | 8.07 |
Gm30093 |
predicted gene, 30093 |
44826 |
0.09 |
chr18_64013723_64014176 | 8.06 |
Gm6974 |
predicted gene 6974 |
67471 |
0.1 |
chr6_23459950_23460194 | 8.04 |
Gm27959 |
predicted gene, 27959 |
59674 |
0.13 |
chr4_70365409_70365768 | 8.01 |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
37953 |
0.22 |
chr11_92135029_92135209 | 7.98 |
Gm22702 |
predicted gene, 22702 |
110706 |
0.08 |
chr12_16643779_16644298 | 7.98 |
Lpin1 |
lipin 1 |
2928 |
0.23 |
chr10_83102752_83102925 | 7.94 |
1700025N21Rik |
RIKEN cDNA 1700025N21 gene |
39200 |
0.14 |
chr4_86020767_86020977 | 7.94 |
Gm25811 |
predicted gene, 25811 |
22622 |
0.23 |
chr10_59089858_59090131 | 7.94 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
9960 |
0.24 |
chr2_132029196_132030408 | 7.94 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr11_34348265_34348533 | 7.91 |
Insyn2b |
inhibitory synaptic factor family member 2B |
33577 |
0.16 |
chr2_130491627_130491927 | 7.91 |
9530056E24Rik |
RIKEN cDNA 9530056E24 gene |
32218 |
0.08 |
chr14_11683845_11684071 | 7.91 |
Gm48602 |
predicted gene, 48602 |
83985 |
0.09 |
chr18_61900936_61901333 | 7.90 |
Ablim3 |
actin binding LIM protein family, member 3 |
10689 |
0.19 |
chr3_108411068_108411422 | 7.88 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4307 |
0.11 |
chr2_3117961_3119194 | 7.87 |
Fam171a1 |
family with sequence similarity 171, member A1 |
108 |
0.97 |
chr14_60554058_60554987 | 7.86 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr6_17142768_17142919 | 7.83 |
Gm4876 |
predicted gene 4876 |
28622 |
0.17 |
chr11_33336545_33336696 | 7.83 |
Ranbp17 |
RAN binding protein 17 |
6605 |
0.22 |
chr1_153665473_153665697 | 7.82 |
Rgs8 |
regulator of G-protein signaling 8 |
8 |
0.97 |
chr3_105569533_105569784 | 7.80 |
Gm43847 |
predicted gene 43847 |
66751 |
0.09 |
chr7_141060848_141061734 | 7.79 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
74 |
0.93 |
chr15_25278577_25278822 | 7.79 |
9230109A22Rik |
RIKEN cDNA 9230109A22 gene |
39869 |
0.13 |
chr1_75289710_75289861 | 7.79 |
Resp18 |
regulated endocrine-specific protein 18 |
11370 |
0.08 |
chr2_132879507_132880005 | 7.79 |
Lrrn4 |
leucine rich repeat neuronal 4 |
1135 |
0.42 |
chr5_149495653_149495848 | 7.78 |
Gm2566 |
predicted gene 2566 |
7302 |
0.14 |
chr3_21798223_21798445 | 7.77 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
2439 |
0.4 |
chr13_70096512_70096709 | 7.76 |
Gm47656 |
predicted gene, 47656 |
35052 |
0.14 |
chr11_96903282_96903520 | 7.75 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
5357 |
0.1 |
chr13_36283759_36283936 | 7.74 |
Gm48766 |
predicted gene, 48766 |
31488 |
0.17 |
chr8_32883706_32884108 | 7.72 |
Nrg1 |
neuregulin 1 |
45 |
0.99 |
chr5_54158308_54158653 | 7.70 |
Stim2 |
stromal interaction molecule 2 |
42623 |
0.18 |
chr6_101211344_101211690 | 7.67 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
12317 |
0.17 |
chr9_16399054_16399273 | 7.66 |
Fat3 |
FAT atypical cadherin 3 |
20932 |
0.24 |
chr9_14032090_14032250 | 7.63 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
57450 |
0.11 |
chr17_70633313_70633464 | 7.63 |
Dlgap1 |
DLG associated protein 1 |
71836 |
0.11 |
chr8_4206127_4207837 | 7.63 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr3_8561664_8561822 | 7.59 |
Stmn2 |
stathmin-like 2 |
1477 |
0.43 |
chr7_51772714_51772887 | 7.59 |
Gm29296 |
predicted gene 29296 |
74 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 29.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
6.7 | 20.1 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
5.9 | 5.9 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
5.6 | 28.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
5.5 | 22.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
4.8 | 4.8 | GO:0021550 | medulla oblongata development(GO:0021550) |
4.6 | 13.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
4.5 | 27.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
4.4 | 17.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.2 | 12.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
4.1 | 16.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.0 | 12.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.0 | 15.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
3.9 | 11.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
3.9 | 11.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
3.9 | 11.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
3.8 | 19.0 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.5 | 10.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.2 | 6.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.2 | 6.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
3.2 | 9.6 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
3.2 | 6.3 | GO:0030035 | microspike assembly(GO:0030035) |
3.1 | 12.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.1 | 9.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.1 | 9.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
3.1 | 12.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.1 | 9.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.0 | 9.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
3.0 | 9.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.0 | 18.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
3.0 | 14.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.9 | 14.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.9 | 20.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
2.9 | 17.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.8 | 2.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.8 | 2.8 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.8 | 25.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.8 | 2.8 | GO:0021586 | pons maturation(GO:0021586) |
2.7 | 8.2 | GO:0060066 | oviduct development(GO:0060066) |
2.7 | 8.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.7 | 8.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.7 | 8.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.6 | 10.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.5 | 15.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.5 | 10.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.5 | 45.2 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
2.5 | 10.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.5 | 5.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.5 | 7.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.5 | 7.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.5 | 9.9 | GO:0021554 | optic nerve development(GO:0021554) |
2.5 | 9.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.4 | 9.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.4 | 4.8 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.4 | 7.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
2.3 | 7.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.3 | 6.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.3 | 4.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
2.2 | 4.4 | GO:0060166 | olfactory pit development(GO:0060166) |
2.2 | 8.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.2 | 6.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.2 | 2.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.1 | 6.4 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.1 | 8.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.1 | 10.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.1 | 4.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.1 | 8.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.1 | 6.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.1 | 4.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
2.1 | 4.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
2.0 | 4.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.0 | 4.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.0 | 10.0 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.0 | 8.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.0 | 6.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
2.0 | 8.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.0 | 7.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.9 | 7.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.9 | 5.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.9 | 9.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.9 | 1.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.9 | 43.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.9 | 5.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.9 | 24.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.9 | 1.9 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.9 | 11.1 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.8 | 3.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.8 | 5.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.8 | 7.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.8 | 7.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.8 | 9.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
1.8 | 5.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.8 | 9.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.8 | 3.7 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.8 | 11.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.8 | 7.2 | GO:0007412 | axon target recognition(GO:0007412) |
1.8 | 3.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 7.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.7 | 3.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.7 | 3.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.7 | 3.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.7 | 5.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.7 | 10.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.7 | 5.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.7 | 5.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.7 | 3.4 | GO:0048664 | neuron fate determination(GO:0048664) |
1.7 | 5.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.7 | 8.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.7 | 6.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.7 | 5.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.6 | 3.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.6 | 8.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.6 | 32.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.6 | 1.6 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
1.6 | 9.7 | GO:0071625 | vocalization behavior(GO:0071625) |
1.6 | 4.8 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.6 | 8.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
1.6 | 16.1 | GO:0008038 | neuron recognition(GO:0008038) |
1.6 | 6.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.6 | 1.6 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.6 | 4.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.6 | 1.6 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.6 | 6.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.6 | 6.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.5 | 7.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.5 | 3.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.5 | 18.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.5 | 15.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.5 | 9.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.5 | 3.0 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.5 | 4.5 | GO:0001927 | exocyst assembly(GO:0001927) |
1.5 | 7.3 | GO:0048840 | otolith development(GO:0048840) |
1.4 | 2.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.4 | 2.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.4 | 5.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.4 | 5.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.4 | 2.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.4 | 4.2 | GO:0060618 | nipple development(GO:0060618) |
1.4 | 2.8 | GO:0009629 | response to gravity(GO:0009629) |
1.4 | 5.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.4 | 19.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.4 | 15.4 | GO:0036065 | fucosylation(GO:0036065) |
1.4 | 4.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.4 | 4.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.4 | 2.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.4 | 6.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.4 | 2.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.4 | 4.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.4 | 1.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.4 | 5.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.4 | 4.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 2.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.3 | 29.4 | GO:0001964 | startle response(GO:0001964) |
1.3 | 4.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.3 | 2.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.3 | 4.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.3 | 15.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.3 | 3.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.3 | 3.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.3 | 7.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.3 | 10.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.3 | 5.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
1.3 | 5.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.3 | 5.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 5.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.3 | 2.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.2 | 3.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.2 | 1.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.2 | 4.9 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.2 | 12.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.2 | 3.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 9.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.2 | 3.6 | GO:0097503 | sialylation(GO:0097503) |
1.2 | 1.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
1.2 | 4.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.2 | 5.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.2 | 2.3 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.1 | 2.3 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 4.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.1 | 55.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 3.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.1 | 8.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.1 | 6.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.1 | 3.3 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.1 | 2.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.1 | 6.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.1 | 3.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.1 | 4.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.1 | 2.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
1.1 | 3.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.0 | 1.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
1.0 | 3.1 | GO:0030070 | insulin processing(GO:0030070) |
1.0 | 2.1 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
1.0 | 15.7 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
1.0 | 10.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 1.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.0 | 3.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.0 | 3.1 | GO:0060005 | vestibular reflex(GO:0060005) |
1.0 | 1.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.0 | 27.7 | GO:0019228 | neuronal action potential(GO:0019228) |
1.0 | 3.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 4.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.0 | 4.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 11.0 | GO:0010842 | retina layer formation(GO:0010842) |
1.0 | 3.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.0 | 4.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 2.0 | GO:0060513 | prostatic bud formation(GO:0060513) |
1.0 | 3.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.0 | 3.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.0 | 4.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 2.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.0 | 5.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.9 | 0.9 | GO:0048880 | sensory system development(GO:0048880) |
0.9 | 2.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 1.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.9 | 2.8 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.9 | 1.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.9 | 3.7 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.9 | 3.7 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 9.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.9 | 9.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.9 | 4.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.9 | 2.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.9 | 1.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.9 | 1.8 | GO:0008355 | olfactory learning(GO:0008355) |
0.9 | 7.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.9 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.9 | 1.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 3.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.9 | 2.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.9 | 1.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 2.7 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.9 | 5.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.9 | 5.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.9 | 2.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.9 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 6.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.9 | 0.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.9 | 0.9 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.9 | 1.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.9 | 5.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.9 | 3.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.8 | 3.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.8 | 2.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.8 | 2.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 2.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 1.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 12.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 3.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 2.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.8 | 1.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.8 | 2.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.8 | 0.8 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.8 | 5.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.8 | 2.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.8 | 0.8 | GO:0051794 | regulation of catagen(GO:0051794) |
0.8 | 1.6 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.8 | 0.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.8 | 2.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.8 | 1.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.8 | 3.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.8 | 2.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.8 | 3.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 1.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.7 | 0.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 2.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.7 | 4.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.7 | 12.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 1.5 | GO:0030432 | peristalsis(GO:0030432) |
0.7 | 2.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.7 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.7 | 5.8 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.7 | 2.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.7 | 2.9 | GO:0046958 | nonassociative learning(GO:0046958) |
0.7 | 49.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.7 | 1.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.7 | 0.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.7 | 2.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.7 | 2.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.7 | 1.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.7 | 4.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.7 | 1.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 1.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 8.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.7 | 1.4 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.7 | 0.7 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 0.7 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.7 | 4.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.7 | 2.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 5.4 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.7 | 0.7 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.7 | 2.7 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 1.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.7 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 0.7 | GO:0002125 | aggressive behavior(GO:0002118) maternal aggressive behavior(GO:0002125) |
0.7 | 2.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.7 | 5.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.7 | 2.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 2.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 3.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.6 | 1.9 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 1.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 5.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.6 | 1.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 0.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 2.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 2.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 1.2 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.6 | 1.2 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 1.2 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 10.8 | GO:0007416 | synapse assembly(GO:0007416) |
0.6 | 2.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.6 | 3.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 0.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.6 | 1.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.6 | 0.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 3.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.6 | 1.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 4.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 3.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.6 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 0.6 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.6 | 2.3 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 1.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 6.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.6 | 1.7 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.6 | 3.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 0.6 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.6 | 5.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.6 | 1.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.6 | 4.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 1.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 1.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 1.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.5 | 1.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 1.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.5 | 1.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 2.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 3.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 1.6 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.5 | 0.5 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.5 | 1.6 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 3.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.5 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.5 | 5.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.5 | 1.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.5 | 1.1 | GO:0007379 | segment specification(GO:0007379) |
0.5 | 2.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 1.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.5 | 1.6 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 1.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 6.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.5 | 3.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 0.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.5 | 1.0 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 2.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 1.0 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.5 | 0.5 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
0.5 | 1.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.5 | 3.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.5 | 1.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 1.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 8.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.5 | 1.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.5 | 2.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.5 | 1.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.5 | 1.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 2.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 1.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.5 | 14.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.5 | 1.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 0.5 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.5 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 2.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.5 | 3.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 0.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 0.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.5 | 3.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.5 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 0.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.5 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 1.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 1.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 2.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.4 | 4.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.4 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 1.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.4 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 1.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 0.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 1.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 0.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.4 | 0.4 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.4 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 0.4 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.4 | 1.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.4 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.3 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 9.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 3.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.4 | 3.0 | GO:0001975 | response to amphetamine(GO:0001975) |
0.4 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 1.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 0.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.4 | 2.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.4 | 1.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 1.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 2.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 2.9 | GO:0043586 | tongue development(GO:0043586) |
0.4 | 1.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 36.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.4 | 0.4 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.4 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 0.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 4.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.4 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 1.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 1.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 0.8 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 1.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 24.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 1.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 0.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.4 | 4.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 1.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 1.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 2.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 1.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 1.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.7 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 9.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 1.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 2.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.3 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 0.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 0.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 1.3 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 3.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 2.0 | GO:0098868 | bone growth(GO:0098868) |
0.3 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 0.7 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 0.6 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 1.9 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.6 | GO:0072044 | collecting duct development(GO:0072044) |
0.3 | 2.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 0.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 1.9 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 7.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 0.3 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 2.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.3 | 1.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 2.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 0.9 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 0.9 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 2.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 2.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 1.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 1.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 0.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.5 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 1.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.3 | GO:0021544 | subpallium development(GO:0021544) |
0.2 | 0.5 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 2.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 3.9 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 2.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.7 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.9 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 2.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 3.7 | GO:0097009 | energy homeostasis(GO:0097009) |
0.2 | 1.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.6 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.6 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.8 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 1.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 1.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 4.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 4.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 2.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 2.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.6 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 2.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.7 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 1.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 1.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.7 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 2.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 2.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.1 | 0.4 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 1.3 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 1.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 1.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 1.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 2.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 1.1 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.5 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.3 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.5 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.5 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 2.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 4.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 8.3 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.3 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.3 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:0086009 | membrane repolarization(GO:0086009) |
0.1 | 0.2 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:2000860 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.1 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0002836 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.0 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0090670 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:1900449 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 14.8 | GO:0072534 | perineuronal net(GO:0072534) |
3.5 | 13.8 | GO:1990696 | USH2 complex(GO:1990696) |
3.0 | 35.6 | GO:0043194 | axon initial segment(GO:0043194) |
2.9 | 8.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.9 | 20.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.7 | 13.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.5 | 47.7 | GO:0030673 | axolemma(GO:0030673) |
2.4 | 7.2 | GO:0032280 | symmetric synapse(GO:0032280) |
2.3 | 2.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.1 | 6.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.0 | 17.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.0 | 15.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.9 | 5.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.9 | 11.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.7 | 7.0 | GO:0044308 | axonal spine(GO:0044308) |
1.7 | 10.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.7 | 3.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.7 | 13.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.7 | 5.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.7 | 3.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.6 | 4.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.6 | 1.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.6 | 4.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.6 | 28.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.5 | 7.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.5 | 3.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.5 | 23.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.4 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 5.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.4 | 83.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.4 | 7.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.4 | 10.9 | GO:0001520 | outer dense fiber(GO:0001520) |
1.3 | 4.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.3 | 45.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.3 | 3.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.3 | 5.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.2 | 3.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.2 | 3.5 | GO:0033010 | paranodal junction(GO:0033010) |
1.2 | 19.6 | GO:0005614 | interstitial matrix(GO:0005614) |
1.1 | 3.4 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 3.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 5.5 | GO:0097433 | dense body(GO:0097433) |
1.1 | 175.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.0 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.0 | 13.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 28.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 8.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.8 | 1.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.8 | 2.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 0.8 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.8 | 6.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.8 | 30.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.8 | 14.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 9.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.8 | 2.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.8 | 1.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.8 | 3.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.8 | 3.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 9.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.7 | 93.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 3.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 5.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 1.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 9.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 1.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.6 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 54.6 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.6 | 1.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 4.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 2.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 1.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 5.0 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 3.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 23.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 4.6 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 4.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 2.2 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 2.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 2.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.3 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 0.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 4.6 | GO:0043205 | fibril(GO:0043205) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 6.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.3 | 1.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 1.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.6 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 5.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 3.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 2.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.3 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.9 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.0 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 7.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.6 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 2.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 36.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 1.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 6.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 3.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 2.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 21.0 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 2.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 1.7 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 1.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 1.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 23.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.4 | 19.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
5.3 | 26.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
4.1 | 12.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
4.0 | 8.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.0 | 11.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.7 | 14.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.7 | 11.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.6 | 10.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.5 | 17.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.5 | 14.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.4 | 20.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
3.3 | 6.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.0 | 17.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
3.0 | 14.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.9 | 11.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.8 | 2.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
2.7 | 8.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.5 | 12.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.4 | 14.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.3 | 4.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
2.3 | 9.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.3 | 6.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.2 | 13.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.2 | 8.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.1 | 10.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
2.1 | 6.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.0 | 8.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
2.0 | 6.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.0 | 3.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.0 | 39.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.9 | 5.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.9 | 3.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.8 | 7.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.8 | 9.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.8 | 16.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 19.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.7 | 7.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.7 | 5.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.7 | 31.1 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.7 | 5.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.6 | 18.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.6 | 3.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.6 | 7.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.5 | 6.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.5 | 4.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.5 | 4.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.5 | 15.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 19.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.5 | 4.5 | GO:0035939 | microsatellite binding(GO:0035939) |
1.5 | 10.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.4 | 25.0 | GO:0005112 | Notch binding(GO:0005112) |
1.4 | 5.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 4.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.3 | 6.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.3 | 41.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.3 | 5.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.3 | 3.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.3 | 29.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.2 | 3.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.2 | 5.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.2 | 4.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.2 | 3.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 4.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.2 | 1.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 3.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.2 | 5.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.2 | 4.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.2 | 1.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.2 | 6.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.1 | 12.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.1 | 2.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.1 | 5.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.1 | 13.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.1 | 5.6 | GO:0017040 | ceramidase activity(GO:0017040) |
1.1 | 28.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.1 | 14.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.1 | 3.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.1 | 5.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 9.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.0 | 5.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.0 | 4.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.0 | 2.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.0 | 3.0 | GO:0051373 | FATZ binding(GO:0051373) |
1.0 | 2.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.0 | 23.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 0.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.9 | 1.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.9 | 2.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 11.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.9 | 21.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 2.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 3.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.9 | 5.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.9 | 1.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 3.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 4.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.8 | 4.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 2.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 6.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 7.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.8 | 6.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.8 | 3.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 3.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.7 | 6.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 45.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.7 | 2.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.7 | 2.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.7 | 9.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.7 | 13.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 2.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 2.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 6.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.7 | 14.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 2.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 7.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 1.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.7 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 2.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.7 | 3.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 6.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.6 | 2.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 8.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 2.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 1.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.6 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 13.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 5.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.6 | 2.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 1.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 1.7 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.6 | 3.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 16.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 6.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 6.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 5.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.6 | 5.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 3.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 3.8 | GO:0034560 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 7.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.5 | 1.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 12.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 2.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 1.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 5.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 11.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 3.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 2.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 0.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 4.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 9.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 6.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 6.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 4.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 9.4 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 3.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 9.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 0.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 1.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 1.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 2.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 1.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 18.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.4 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 6.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 3.6 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.4 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 1.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 4.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 2.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 7.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 3.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 1.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 2.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 8.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 8.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 1.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.6 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 0.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 4.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 3.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 6.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 3.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 2.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 2.8 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 5.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.8 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.6 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.2 | 0.2 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 2.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 4.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 2.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.7 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 7.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 8.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 3.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 2.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 2.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 2.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 4.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 2.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 2.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 3.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 2.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 1.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 8.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 2.1 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 5.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 13.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 4.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.8 | 26.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.6 | 9.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.4 | 46.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 1.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 0.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.9 | 10.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.8 | 10.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 3.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.8 | 19.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.7 | 6.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.7 | 10.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 13.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 16.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 2.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 2.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.5 | 7.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 8.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 14.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 0.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 4.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 7.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 7.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 5.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 5.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 2.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 6.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 3.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 2.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 10.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 9.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 3.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 2.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 50.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 2.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 8.2 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 5.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 3.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 6.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 30.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 3.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 5.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.3 | 2.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
2.2 | 24.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.9 | 17.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.9 | 38.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.8 | 25.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.7 | 23.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.6 | 16.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.5 | 1.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.5 | 23.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.4 | 14.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.4 | 33.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.4 | 31.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.4 | 4.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.3 | 22.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.3 | 14.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.3 | 54.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 13.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.1 | 2.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.1 | 2.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
1.0 | 2.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.0 | 18.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.9 | 10.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.9 | 15.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 4.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 20.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.9 | 1.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.8 | 1.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.8 | 0.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 11.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.7 | 12.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 6.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 2.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 7.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 4.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 13.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 6.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 8.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 7.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 3.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 25.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.5 | 6.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 6.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 3.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.4 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 2.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 8.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 7.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 22.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 4.7 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.3 | 7.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 11.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 9.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 11.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 1.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 2.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 4.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 11.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 3.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 3.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.6 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 4.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |